Heparin Market to Advance at CAGR of 6.8% During 2019-2027: TMR Report – QNT Press Release

  • Demand for heparin drugs for treatment of various thrombotic events to steer revenue generation; availability of affordable heparin products especially to elderly patient population enriching heparin market prospects
  • Need to reduce mortality of coagulation disorders in adults spurring demand; high prevalence of coronary heart disease and deep vein thrombosis in North America makes the region lucrative

WILMINGTON, Del., Aug. 26, 2022 /PRNewswire/ — The heparin market size was pegged at US$ 10.8 Bn in 2018, reinforced by its abundant applications as anticoagulant in various clinical settings over the years. A scrutiny of recent heparin market trends indicate that launch of safer, cost-effective, and more efficacious heparin drugs has helped reduce prevalence of cardiovascular diseases (CVD). Of note, the products have grown in demand for treating coronary heart disease and deep vein thrombosis, found an in- depth heparin market revenue analysis.

The demand for anticoagulants including heparin has been growing in the patient populations for managing various lung, heart, and blood vessel, and heart diseases, notably in hospitals, which thus has enriched heparin market outlook considerably. Aside from increasing the affordability, stakeholders are also leaning on commercializing heparin products with less risks of the typical side effects. Stridently, the need has spurred R&D in low molecular weight heparin (LMWH), observed the study authors.

Get Exclusive PDF Sample Copy of Heparin Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=803

Key Findings of Heparin Market Study

  • Rising Use in Various Indications of Thrombotic Events Propelling Product Sales: The mortality of coronary heart disease along with their risk factors has spurred the demand for various heparin products. Wide use of anticoagulant drugs in various indications have stirred lucrative opportunities which market players have tapped into over the past several years. Clinicians have been found to better manage major complication associated with heparin’s use, such as bleeding, thereby positively impacted the demand in heparin market.
  • Use of Heparin Drugs in Managing Coagulation Disorders Underpins Vast Profitable Avenue: Widespread need for anticoagulant therapies in various cardiovascular diseases and venous thromboembolism has reinforced potential revenues in heparin market. Affordability of heparin drugs and the fact that they have proved to be safe in the prevention and treatment of several thrombotic …

Full story available on Benzinga.com

Source link

Recommended For You

About the Author: News Center